At INNODAIRY 2026, ProGnosis Biotech advanced a more preventive approach to antibiotic residue control, connecting rapid testing with faster decisions across dairy production.
ProGnosis Biotech participated in INNODAIRY 2026, held from 16-19 June in Poland, bringing a clear perspective to one of the dairy sector’s most important quality-control challenges: antibiotic residue testing must do more than confirm compliance. It must support action when that action can still make a difference.
At this event, ProGnosis Biotech challenged the conventional view of antibiotic screening as a final checkpoint. Instead, the company positioned timely testing as an operational tool that can give dairy professionals greater control before milk enters production and before an isolated issue develops into a wider production, quality or safety risk.
At INNODAIRY, the discussion moved beyond the consequences of antibiotic residues to a more practical question: how can dairy professionals access dependable results at the point where critical decisions are being made?
Prognosis’ presentation demonstrated an approach built around rapid screening, straightforward interpretation and digital result management, connecting analytical performance with the realities of daily dairy operations. The objective is not to add another layer of complexity, but to make antibiotic control easier to perform, document and integrate across milk reception, laboratory testing and production environments.
“At INNODAIRY, we wanted to move the discussion from testing as an obligation to testing as a decision-making tool,” said Justyna Liwinska, Key Account Manager at ProGnosis Biotech. “When results are available at the right moment, dairy professionals can respond earlier, protect production and prevent a potential issue from affecting product quality or consumer confidence.”
The impact of INNODAIRY extended beyond the presentation. Exchanges with dairy producers, researchers, quality professionals and other industry stakeholders brought the operational realities of antibiotic control directly into the discussion, from pressure for faster release decisions to the need for reliable, traceable and easily implemented testing workflows.
ProGnosis Biotech continues to contribute to that shift by connecting diagnostic expertise with the demands of real dairy production. The conversation that took place at INNODAIRY does not end with the event. It continues in laboratories, at milk reception points and across production facilities where faster access to reliable information can strengthen control, protect product quality and support safer dairy production.
